Close

Analyst Ratings for Prelude Therapeutics (PRLD)

PRLD Rating Summary

PRLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PRLD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $4.67 (+14.1%) * Over Last 12-Mos
Rating Score: 1.7 / 10   Percentile Rank: 12%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/20/2024 H.C. Wainwright Robert Burns Downgrade Neutral
(Buy)
5.00
(N/A)
4.63
(4.09)
-11.66% Details
12/19/2023 Morgan Stanley Jeffrey Hung Downgrade Underweight
(Equalweight)
4.00
(10.00)
4.35
(4.09)
-5.98% Details
Like PRLD Ratings? Also take a look at ABCL

PRLD Ratings News